These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies. Davidson YS, Robinson AC, Rollinson S, Pickering-Brown S, Xiao S, Robertson J, Mann DMA. Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb 20; 19(1-2):102-111. PubMed ID: 28766957 [Abstract] [Full Text] [Related]
28. Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity. Quaegebeur A, Glaria I, Lashley T, Isaacs AM. Acta Neuropathol Commun; 2020 Nov 09; 8(1):184. PubMed ID: 33168090 [Abstract] [Full Text] [Related]
29. Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity. Bennett CL, Dastidar S, Arnold FJ, McKinstry SU, Stockford C, Freibaum BD, Sopher BL, Wu M, Seidner G, Joiner W, Taylor JP, West RJH, La Spada AR. Acta Neuropathol Commun; 2023 Oct 17; 11(1):164. PubMed ID: 37845749 [Abstract] [Full Text] [Related]
32. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Mori K, Arzberger T, Grässer FA, Gijselinck I, May S, Rentzsch K, Weng SM, Schludi MH, van der Zee J, Cruts M, Van Broeckhoven C, Kremmer E, Kretzschmar HA, Haass C, Edbauer D. Acta Neuropathol; 2013 Dec 17; 126(6):881-93. PubMed ID: 24132570 [Abstract] [Full Text] [Related]
34. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels. Beckers J, Tharkeshwar AK, Van Damme P. Autophagy; 2021 Nov 17; 17(11):3306-3322. PubMed ID: 33632058 [Abstract] [Full Text] [Related]
35. Co-incidental C9orf72 expansion mutation-related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt-Jakob disease. Klotz S, König T, Erdler M, Ulram A, Nguyen A, Ströbel T, Zimprich A, Stögmann E, Regelsberger G, Höftberger R, Budka H, Kovacs GG, Gelpi E. Eur J Neurol; 2021 Mar 17; 28(3):1009-1015. PubMed ID: 33131137 [Abstract] [Full Text] [Related]
36. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Hortobágyi T, Troakes C, Nishimura AL, Vance C, van Swieten JC, Seelaar H, King A, Al-Sarraj S, Rogelj B, Shaw CE. Acta Neuropathol; 2011 Apr 17; 121(4):519-27. PubMed ID: 21360076 [Abstract] [Full Text] [Related]
37. Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS. LaClair KD, Zhou Q, Michaelsen M, Wefers B, Brill MS, Janjic A, Rathkolb B, Farny D, Cygan M, de Angelis MH, Wurst W, Neumann M, Enard W, Misgeld T, Arzberger T, Edbauer D. Acta Neuropathol; 2020 Aug 17; 140(2):121-142. PubMed ID: 32562018 [Abstract] [Full Text] [Related]